Floatz logo

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-

Neurologically Impaired

Gillette Children's Specialty HealthcareSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

35 Active assets in the Neurologically Impaired cohort.

Asset / SponsorPhaseRating
Guanfacine
Maimonides Medical Center
Phase 4BB
Ginkgolide
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Opc-34712
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
Live Combined Bifidobacterium,Lactobacillus And Enterococcus Capsules
Beijing Friendship Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- is also rated in:

diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
Neuralgia, PostherpeticDormant
BBB
Indicative ·
77 / 100
View asset →
focal epilepsyDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →